Within two to four weeks we find potential targets/biomarker candidates or do a detailed target/biomarker assessment. This will save you months of painstaking on-line desk research. Enter your contact details and we’ll contact you to discuss next steps.

Use our platform to find novel target/biomarker candidates or do detailed target/biomarker assessment yourselves. This will save you months of painstaking on-line desk research. Enter your contact details and we’ll set up a demo to show you!

Please contact me to discuss:

Subscription to Euretos AI Platform
Euretos consulting service
Direct access to Euretos API



Login
Demo
Consulting
News
VALIDATE
TARGETS ON EFFICACY
SAFETY & DRUGGABILITY

ASK EURETOS

In Silico
Target Validation

Evaluate how a gene interacts within the molecular mechanisms that drive the cell, tissue functions and phenotypes associated with your disease of interest. Ask Euretos and do days if not weeks of online desk research in minutes. Available as platform subscription or consulting service.



TARGET VALIDATION EXAMPLE

ASK EURETOS
logo

Evaluate all disease related molecular gene interactions

Leverage gene-disease annotations from over 200+ data sources in Euretos. Analyze all molecular interactions of the gene of interest but only where the interactors are disease related. For example differentially expression analysis provides only those genes that interact with the gene of interest and are differentially expressed for the disease

alysis

Evaluate target/biomarker suitability on 10 separate criteria

Evaluate 10 key aspects that are relevant to assess a gene as a viable target or biomarker for a disease including healthy expression, differential expression, gene variants, animal models, gene, protein & metabolite interactions, phenotypes, pathways, cell & molecular function and organ & tissue functions.

alysis

Summary of Target Validation Capabilities

Healthy expression - Healthy RNA (fpkm) and protein expression (abundance) of the gene of interest from 5 expression sources including the identification of key associated tissues for the disease based on literature co-occurrence analysis.

Genetic annotations - Direct disease annotations for the gene of interest and all other disease annotated genes having molecular interaction with the gene of interest.

Differential Expression - Differential expression of the gene of interest and any other differentially expressed gene having molecular interaction with the gene of interest (with log2fold expression level).

Gene variants - Known disease causing mutations for the gene of interest and any other disease variant gene having molecular interaction with the gene of interest.

Animal models - Manipulated genes in animal models of the disease, and their molecular interactions with the gene of interest.

Metabolites - All disease associated metabolites that interact with the gene of interest and all disease associated metabolites that interact with genes having molecular interaction with the gene of interest.

Phenotypes - All phenotypes that are significantly associated with the entire set of genes that have molecular interaction with the gene of interest.

Pathways - All Pathways that are significantly associated with the entire set of genes that have molecular interaction with the gene of interest.

Cell or molecular functions - All cell and molecular functions that are significantly associated with the entire set of genes that have molecular interaction with the gene of interest.

Organ and tissue functions - All organ and tissue functions that are significantly associated with the entire set of genes that have molecular interaction with the gene of interest.